Current management and future perspectives of overactive bladder (OAB) pharmacotherapy - Abstract

Department of Pathophysiology, Jagiellonian University, Medical College Czysta 18, 31-121 Kraków, Poland.

 

Overactive bladder (OAB) is a condition characterized by urgency with or without urgency incontinence (UI), usually with increased daytime frequency and nocturia, which affects even 8-14% of adult population. The gold standards of OAB treatment are antimuscarinics, although this clinical entity is often poorly controlled with these agents. Thus, a progress in OAB pharmacotherapy is expected and takes place. The purpose of this article is to short review the present management of the overactive bladder with paying special attention on development of new drugs indicated for OAB treatment.

Written by:
Dobrek Ł, Juszczak K, Wyczółkowski M, Thor PJ.   Are you the author?

Reference: Acta Pol Pharm. 2011 Nov-Dec;68(6):807-21.

PubMed Abstract
PMID: 22125944

UroToday.com Overactive Bladder (OAB) Section

 

SUFU MyBladder app
email news signup